Surmodics outmaneuvers activist investor?

> Drug-delivery company Surmodics may have outmaneuvered an activist investor. Item

> Seattle-based non-profit Infectious Disease Research Institute has received a multimillion-dollar grant from the Defense Advanced Research Projects Agency to develop a novel single dose influenza vaccine to prevent a pandemic flu outbreak. The proposal combines IDRI's vaccine-adjuvant technology and a micro-needle delivery device. Story

> The Nanotechnology Knowledge Transfer Network is planning a conference to discuss the importance of nanotechnology in formulation and drug delivery. More here

> 'Liquid pistons' could drive new advances in camera lenses and drug delivery. Release

> Advances in materials technology are driving the autoinjection drug delivery device market, according to new research. Item

> Switzerland drug delivery company EffRx Pharmaceuticals has submitted an NDA to the FDA for EX101 for the prevention and treatment of osteoporosis in postmenopausal women and the incensement of bone mass in men with osteoporosis. EffRx release

> Drug delivery abstract of the week: Designing dendrimers for drug delivery and imaging: Pharmacokinetic considerations. Abstract

> Drug delivery patent application of the week: Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat. Patent application

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.